← Evidence map

ArticleCancer drug resistance (Alhambra, Calif.)2022

Improving HER2 testing reproducibility in HER2-low breast cancer.

Elham Sajjadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36627898